Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis

被引:159
作者
Ianiro, Gianluca [1 ]
Maida, Marcello [2 ]
Burisch, Johan [3 ]
Simonelli, Claudia [1 ]
Hold, Georgina [4 ]
Ventimiglia, Marco [5 ]
Gasbarrini, Antonio [1 ]
Cammarota, Giovanni [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Gemelli, Gastroenterol Area, A Gemelli 8, I-00168 Rome, Italy
[2] S Elia Raimondi Hosp, Sect Gastroenterol, Caltanissetta, Italy
[3] North Zealand Univ Hosp, Dept Gastroenterol, Frederikssund, Denmark
[4] UNSW Med, St George & Sutherland Clin Sch, Sydney, BC, Australia
[5] Villa Sofia V Cervello Hosp, Sect Internal Med, Palermo, Italy
关键词
Clostridium difficile; systematic review; meta-analysis; faecal microbiota transplantation; faecal transplant; TERM-FOLLOW-UP; RECURRENT; VANCOMYCIN; FROZEN; STOOL;
D O I
10.1177/2050640618780762
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Protocols for treating recurrent Clostridium difficile infection (rCDI) through faecal microbiota transplantation (FMT) are still not standardised. Our aim was to evaluate the efficacy of different FMT protocols for rCDI according to routes, number of infusions and infused material. Methods: MEDLINE, Embase, SCOPUS, Web of Science and the Cochrane Library were searched through 31 May 2017. Studies offering multiple infusions if a single infusion failed to cure rCDI were included. Data were combined through a random effects meta-analysis. Results: Fifteen studies (1150 subjects) were analysed. Multiple infusions increased efficacy rates overall (76% versus 93%) and in each route of delivery (duodenal delivery: 73% with single infusion versus 81% with multiple infusions; capsule: 80% versus 92%; colonoscopy: 78% versus 98% and enema: 56% versus 92%). Duodenal delivery and colonoscopy were associated, respectively, with lower efficacy rates (p = 0.039) and higher efficacy rates (p = 0.006) overall. Faecal amount <= 50 g (p = 0.006) and enema (p = 0.019) were associated with lower efficacy rates after a single infusion. The use of fresh or frozen faeces did not influence outcomes. Conclusions: Routes, number of infusions and faecal dosage may influence efficacy rates of FMT for rCDI. These findings could help to optimise FMT protocols in clinical practice.
引用
收藏
页码:1232 / 1244
页数:13
相关论文
共 36 条
[21]   The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema [J].
Lee, C. H. ;
Belanger, J. E. ;
Kassam, Z. ;
Smieja, M. ;
Higgins, D. ;
Broukhanski, G. ;
Kim, P. T. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (08) :1425-1428
[22]   Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection A Randomized Clinical Trial [J].
Lee, Christine H. ;
Steiner, Theodore ;
Petrof, Elaine O. ;
Smieja, Marek ;
Roscoe, Diane ;
Nematallah, Anouf ;
Weese, J. Scott ;
Collins, Stephen ;
Moayyedi, Paul ;
Crowther, Mark ;
Ropeleski, Mark J. ;
Jayaratne, Padman ;
Higgins, David ;
Li, Yingfu ;
Rau, Neil V. ;
Kim, Peter T. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (02) :142-149
[23]  
Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2700, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299]
[24]  
Ma GK, 2017, ANN INTERN MED, V167, P152, DOI [10.7326/M16-2733, 10.7326/m16-2733]
[25]   Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile [J].
Mandalia, Amar ;
Ward, Angela ;
Tauxe, William ;
Kraft, Colleen S. ;
Dhere, Tanvi .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2016, 31 (05) :1059-1060
[26]   Predictors of fecal transplant failure [J].
Meighani, Alireza ;
Hart, Benjamin R. ;
Mittal, Chetan ;
Miller, Nichole ;
John, Ajin ;
Ramesh, Mayur .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (07) :826-830
[27]   Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection [J].
Millan, Braden ;
Park, Heekuk ;
Hotte, Naomi ;
Mathieu, Olivier ;
Burguiere, Pierre ;
Tompkins, Thomas A. ;
Kao, Dina ;
Madsen, Karen L. .
CLINICAL INFECTIOUS DISEASES, 2016, 62 (12) :1479-1486
[28]   Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection [J].
Quraishi, M. N. ;
Widlak, M. ;
Bhala, N. ;
Moore, D. ;
Price, M. ;
Sharma, N. ;
Iqbal, T. H. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (05) :479-493
[29]  
Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D
[30]   Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections [J].
Surawicz, Christina M. ;
Brandt, Lawrence J. ;
Binion, David G. ;
Ananthakrishnan, Ashwin N. ;
Curry, Scott R. ;
Gilligan, Peter H. ;
McFarland, Lynne V. ;
Mellow, Mark ;
Zuckerbraun, Brian S. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (04) :478-498